EGFR-HER2 inhibitor Canertinib dihydrochloride, Purity ≥98%

Cat. No.: X23-10-ZQ1058

EGFR-HER2 inhibitor Canertinib dihydrochloride, Purity ≥98%

Synonym: Canertinib dihydrochloride; 289499-45-2; Canertinib HCl; Canertinib (dihydrochloride); CI-1033; Canertinib 2HCl; EGFR-HER2 inhibitor

  • MDL: MFCD09954112
  • CAS Number: 289499-45-2
  • Compound CID: 156413
Product Size
50 mg; 100 mg; 250 mg; 500 mg
Price
Datasheet
MSDS
Properties
Description
Canertinib dihydrochloride, soluble in DMSO and water and insoluble in ethanol, is a potent and specific inhibitor of the tyrosine kinase activity of EGFR. It targets EGFR and ErbB2.
Molecular Weight
558.86
Molecular Formula
C24H27Cl3FN5O3
Targets
EGFR: 7.4 nM; ErbB2: 9 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 88 mg/mL (157.46 mM); Water: 18 mg/mL (32.2 mM); Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Canertinib dihydrochloride can be used to irreversibly inhibit EGFR family members for oncology research.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.